Search results
Results from the WOW.Com Content Network
The journal addresses both the potential and the challenges of digital health, including issues of patient privacy, regulatory needs, and safety. By fostering interdisciplinary dialogue and engaging a global community of researchers, clinicians, and policymakers, The Lancet Digital Health is a critical resource for shaping the responsible and ...
Rupa Sarkar is the Editor-in-Chief of The Lancet Digital Health, a gold open access medical journal in the Lancet family published by Elsevier. [1] [2]She conducted her doctoral research at Imperial College London, where she studied RNA biology and its role in human stem cell differentiation.
Richard Charles Horton (born 29 December 1961) is editor-in-chief of The Lancet, a United Kingdom–based medical journal.He is an honorary professor at the London School of Hygiene and Tropical Medicine, University College London, and the University of Oslo.
The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet (scalpel). [3] According to BBC, the journal was initially considered to be radical following its founding.
Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.
Due to high costs, some health plans in the US don't cover weight-loss drugs like semaglutide and tirzepatide. [ 74 ] [ 75 ] [ 76 ] In the United States, as of 2024, about half of private employer-sponsored plans cover these drugs, [ 77 ] Federal Medicare Part D does not, and only a few federally-funded, state-administered Medicaid plans do so.
The third-quarter pass secured the first Titans touchdown of the day. The Vikings blitzed five pass rushers on third-and-10. But Tennessee's offensive line stood its ground to buy Levis time as he ...
Pioglitazone is used to lower blood glucose levels in type 2 diabetes either alone or in combination with sulfonylurea, metformin, or insulin. [1] The effects of pioglitazone have been compared in a Cochrane systematic review to that of other blood sugar lowering-medicine, including metformin, acarbose, and repaglinide, as well as with appropriate diet and exercise, not showing any benefit in ...